A central part of our development strategy is to understand which patients benefit most from visugromab, how treatment modulates anti-tumour immunity, and which biomarkers can guide future clinical development. To advance this work, we are seeking a Senior Scientist / Principal Scientist, Clinical Biomarkers to lead the clinical biomarker and translational research programmes across assigned mid-stage oncology trials.
In this role, you will lead the scientific execution and interpretation of the biomarker programmes for your assigned trials, translating complex biomarker, omics, and clinical data into clear conclusions that inform patient selection, clinical development decisions, and our understanding of visugromab’s mechanism of action. This is a scientifically hands-on role that combines independent data analysis and interpretation with cross-functional project leadership and external scientific oversight.
You will be an integral member of the Translational Research & Clinical Biomarkers team and a central contributor to CatalYm’s Research organisation. You will work closely with Clinical Development, Clinical Pharmacology and Bioanalytics, Bioinformatics, Clinical Data Science, Preclinical Research, and Clinical Biomarker Operations, as well as external scientific partners.
The position may be appointed at Senior Scientist or Principal Scientist level, depending on the successful candidate’s experience, demonstrated scientific independence, and previous scope of clinical biomarker programme leadership.
Ihre E-Mail-Jobbenachrichtigung ist jetzt aktiv!
